Calciphylaxis With Normal Renal and Parathyroid Function

作者: Andrew H. Kalajian , Paula S. Malhotra , Jeffrey P. Callen , Lynn P. Parker

DOI: 10.1001/ARCHDERMATOL.2008.602

关键词:

摘要: Background Calciphylaxis is a life-threatening form of metastatic calcification-induced microvascular occlusion syndrome. Although traditionally observed in patients with end-stage renal disease and/or hyperparathyroidism, the development calciphylaxis “nontraditional” having both normal and parathyroid function has been reported. However, to date there no collective analysis identifying common patient characteristics potentially predisposing nontraditional patients. Observations A 58-year-old woman endometrial carcinoma developed extensive despite presence function. The resolved rapid diagnosis, supportive therapy, medical management. Analysis this case 13 previously reported cases identified following that highlight clinical situations calciphylaxis: hypoalbuminemia, malignant neoplasm, systemic corticosteroid use, anticoagulation warfarin sodium or phenprocoumon, chemotherapy, inflammation, hepatic cirrhosis, protein C S deficiency, obesity, weight loss, infection. Conclusions becoming increasingly observations from study may assist dermatologists diagnosis prompt initiation therapy for devastating disease.

参考文章(42)
Anil K. Goli, Sujatha A. Goli, Lata S. Shah, Ryland P. Byrd, Thomas M. Roy, Calciphylaxis: a rare association with alcoholic cirrhosis. Are deficiencies in protein C and S the cause? Southern Medical Journal. ,vol. 98, pp. 736- 739 ,(2005) , 10.1097/01.SMJ.0000154316.22472.97
S. D. Winter, J. D. Conger, W. E. Huffer, D. C. Kuzela, W. S. Hammond, Soft tissue calcification in chronic dialysis patients American Journal of Pathology. ,vol. 86, pp. 403- 424 ,(1977)
Roger H. Weenig, Pathogenesis of calciphylaxis: Hans Selye to nuclear factor κ-B Journal of the American Academy of Dermatology. ,vol. 58, pp. 458- 471 ,(2008) , 10.1016/J.JAAD.2007.12.006
Lorenz C. Hofbauer, Francesca Gori, B. Lawrence Riggs, David L. Lacey, Colin R. Dunstan, Thomas C. Spelsberg, Sundeep Khosla, Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology. ,vol. 140, pp. 4382- 4389 ,(1999) , 10.1210/ENDO.140.10.7034
Michael Angelis, Linda L Wong, Sally A Myers, Livingston M Wong, Calciphylaxis in patients on hemodialysis: A prevalence study Surgery. ,vol. 122, pp. 1083- 1090 ,(1997) , 10.1016/S0039-6060(97)90212-9
David S Bosler, Mitual B Amin, Farris Gulli, Rajwant K Malhotra, Unusual case of calciphylaxis associated with metastatic breast carcinoma. American Journal of Dermatopathology. ,vol. 29, pp. 400- 403 ,(2007) , 10.1097/DAD.0B013E3180DDB535
Severine M Chavel, Karen S Taraszka, Julie V Schaffer, Rossitza Lazova, Jeffrey S Schechner, Calciphylaxis associated with acute, reversible renal failure in the setting of alcoholic cirrhosis Journal of the American Academy of Dermatology. ,vol. 50, pp. 125- 128 ,(2004) , 10.1016/J.JAAD.2003.11.050
S. R. Maxwell, R. J. Moots, M. J. Kendall, Corticosteroids: do they damage the cardiovascular system? Postgraduate Medical Journal. ,vol. 70, pp. 863- 870 ,(1994) , 10.1136/PGMJ.70.830.863
Glynis Scott, James A. Sloand, Charles W. Francis, Ravindra L. Mehta, Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis The American Journal of Medicine. ,vol. 88, pp. 252- 257 ,(1990) , 10.1016/0002-9343(90)90150-C
Michael J. Ryan, Connie L. Davis, Catherine O. Stehman-Breen, A. Rauf Mazhar, Richard J. Johnson, Daniel Gillen, John C. Stivelman, Risk factors and mortality associated with calciphylaxis in end-stage renal disease Kidney International. ,vol. 60, pp. 324- 332 ,(2001) , 10.1046/J.1523-1755.2001.00803.X